InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Finalizes $2.35 Million Settlement with Former CEO Raza Bokhari
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) has reached a global settlement agreement with former Executive Chairman and CEO Dr. Raza Bokhari, resolving all disputes originating from a 2021 proxy contest. Under the agreement, Bokhari will pay the company $2.35 million USD, bringing complete closure to multiple legal proceedings in both the U.S. and Canada and injecting non-dilutive capital into the business. The settlement, signed by Co-Chairmen…